Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 6 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 5 analysts offering 12 month price targets for PDS Biotechnology Corp have a median target of 9.00, with a high estimate of 21.00 and a low estimate of 7.00. The median estimate represents a 193.16% increase from the last price of 3.07.
High | 584.0% | 21.00 |
Med | 193.2% | 9.00 |
Low | 128.0% | 7.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | +10.76% |
Average growth rate | -12.46% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼